Get started
Author

Maria Mancini

Observed names: M Mancini, M. Mancini, MARIA MANCINI, Mancini, Maria, Maria L. Mancini
ORCID: 0000-0001-9379-7335
Observed ORCID: 0000-0001-9379-7335
OpenAlex ID: A5101996583
The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma
2018 · Narendra Bharathy, Noah E. Berlow, et al. · Science Signaling · 77
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
2019 · Narendra Bharathy, Noah E. Berlow, et al. · Skeletal Muscle · 25
PDF
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
2019 · Noah E. Berlow, Rikhi Rikhi, et al. · BMC Cancer · 21
PDF
Development and Applications of Patient‐Derived Xenograft Models in Humanized Mice for Oncology and Immune‐Oncology Drug Discovery
2017 · Bhavna Verma, Michael Ritchie, et al. · Current Protocols in Pharmacology · 12
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML
2022 · DANIEL H. ALBERT, NEAL C. GOODWIN, et al. · In Vivo · 9
PDF
Endoglin is required in Pax3-derived cells for embryonic blood vessel formation
2015 · K Young, LT Krebs, et al. · Developmental Biology · 9
Abstract 50: HTI-1511, a novel anti-EGFR-ADC, overcomes mutation resistance and demonstrates significant activity against multiple tumor types in preclinical studies
2017 · Jesse D. Bahn, Feng Gao, et al. · Cancer Research · 6
Growth of Malignant Non-CNS Tumors Alters Brain Metabolome
2018 · Anna Kovalchuk, Lilit Nersisyan, et al. · Frontiers in Genetics · 5
PDF
Case report for an adolescent with germline RET mutation and alveolar rhabdomyosarcoma
2020 · Kenneth A. Crawford, Noah E. Berlow, et al. · Molecular Case Studies · 4
PDF
Abstract 4285: Tumor-on-chip co-culture system: A comprehensive tool in personalized medicine to study cancer progression
2024 · Samaneh Kamali, Mara Gilardi, et al. · Cancer Research · 2
Abstract 4744: A prospective biospecimen collection study from patients with EGFR mutant tumors
2019 · Ivy B. Elkins, Jill Feldman, et al. · Cancer Research · 1
Abstract A016: NOG-EXL mice have superior immune cell engraftment and lineage development in the human immune system (HIS) model, the ImmunoGraft
2018 · Bhavna Verma, Maria Mancini, et al. · Molecular Cancer Therapeutics · 1
1079 Development of a biologically aligned ex vivo TumorGraft3D platform to evaluate STC-1010-mediated immune priming and colorectal tumor killing
2026 · Ignacio Melero, Margaux Frot, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 3116: Bioluminescent 3D tumors with immune cell co-culture for high throughput screening (HTS)
2024 · Fu-Ju Chou, Samaneh Kamali, et al. · Cancer Research
Abstract 3115: Systematic analysis of gene mutations and therapeutic efficacy via ex vivo hematological vitroscreen platform
2024 · Fu-Ju Chou, Stefano Cairo, et al. · Cancer Research
Abstract 4258: An innovative PDX and patient-derived 3D platform for improved translatability of new medical entities
2024 · Samaneh Kamali, Stefano Cairo, et al. · Cancer Research
Abstract 4257: A novel 3D co-culture platform for patient-specific immune-oncology treatment
2024 · Taylor Light, Samaneh Kamali, et al. · Cancer Research
Deep Immunophenotyping Using High Complexity Flow Cytometry in Acute Myeloid Leukemia
2023 · Jessica Pearl, Elena Bruni, et al. · Blood
PDF
476 Development of a flow cytometric receptor occupancy assay for clinical analysis of immune checkpoint inhibitor therapeutics
2023 · Haoting Hsu, Jessica Pearl, et al. · Journal for ImmunoTherapy of Cancer
PDF
1479 A Novel TumorGraft3D immune co-culture platform for high throughput immune-oncology screening
2023 · Taylor Light, Vaishnavi Sambandam, et al. · Journal for ImmunoTherapy of Cancer
PDF
1286 A novel gene signature predicts immune infiltration phenotypes in humanized patient derived xenograft models
2023 · Mara Gilardi, Gilad Silberberg, et al. · Journal for ImmunoTherapy of Cancer
PDF
25 Establishment of tumor-on-chip system to study the role of tumor microenvironment on cancer progression in a patient-specific manner
2023 · Samaneh Kamali, Mara Gilardi, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 207: Ex vivo modeling of multiple myeloma: A novel drug sensitivity screening platform
2023 · Vaishnavi Sambandam, Sharvari Inamdar, et al. · Cancer Research
A prospective correlative trial of personalized patient-derived xenograft (PDX) as avatars for drug therapy in patients with metastatic or recurrent soft tissue sarcomas (STS)
2019 · K. Alshammari, E.M. Al-ezzi, et al. · Annals of Oncology
Additional file 31: of Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
2019 · Berlow, Noah, Rishi Rikhi, et al. · Figshare
Works count: 55
Citation count: 172
H-index: 6
I10-index: 4
Year
Topic
Type